Takahiro Itou1, Natalia Maldonado, Iwao Yamada, Claudia Goettsch, Jiro Matsumoto, Masanori Aikawa, Sasha Singh, Elena Aikawa. 1. From the Division of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences (T.I., N.M., I.Y., C.G., J.M., M.A., S.S., E.A.), Channing Division of Network Medicine (M.A.), and Division of Cardiovascular Medicine, Center for Excellence in Vascular Biology (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and Kowa Company, Ltd, Tokyo, Japan (T.I., I.Y., J.M.).
Abstract
OBJECTIVE: Clinical evidence has linked vascular calcification in advanced atherosclerotic plaques with overt cardiovascular disease and mortality. Bone resorbing monocyte-derived osteoclast-like cells are sparse in these plaques, indicating that their differentiation capability could be suppressed. Here, we seek to characterize the process of osteoclastogenesis by identifying novel regulators and pathways, with the aim of exploring possible strategies to reduce calcification. APPROACH AND RESULTS: We used a quantitative mass spectrometry strategy, tandem mass tagging, to quantify changes in the proteome of osteoclast-like cells differentiated from RAW264.7 cells in response to, receptor activator of nuclear factor κ-B ligand induction, a common in vitro model for osteogenesis. More than 4000 proteins were quantified, of which 138 were identified as novel osteoclast-related proteins. We selected 5 proteins for subsequent analysis (cystathionine γ-lyase [Cth/CSE], EGF-like repeat and discoidin I-like domain-containing protein 3, integrin α FG-GAP repeat containing 3, adseverin, and serpinb6b) and show that gene expression levels are also increased. Further analysis of the CSE transcript profile reveals an early onset of an mRNA increase. Silencing of CSE by siRNA and dl-propargylglycine, a CSE inhibitor, attenuated receptor activator of nuclear factor κ-B ligand-induced tartrate-resistant acid phosphatase type 5 activity and pit formation, suggesting that CSE is a potent inducer of calcium resorption. Moreover, knockdown of CSE suppressed expression of osteoclast differentiation markers. CONCLUSIONS: Our large-scale proteomics study identified novel candidate regulators or markers for osteoclastogenesis and demonstrated that CSE may act in early stages of osteoclastogenesis.
OBJECTIVE: Clinical evidence has linked vascular calcification in advanced atherosclerotic plaques with overt cardiovascular disease and mortality. Bone resorbing monocyte-derived osteoclast-like cells are sparse in these plaques, indicating that their differentiation capability could be suppressed. Here, we seek to characterize the process of osteoclastogenesis by identifying novel regulators and pathways, with the aim of exploring possible strategies to reduce calcification. APPROACH AND RESULTS: We used a quantitative mass spectrometry strategy, tandem mass tagging, to quantify changes in the proteome of osteoclast-like cells differentiated from RAW264.7 cells in response to, receptor activator of nuclear factor κ-B ligand induction, a common in vitro model for osteogenesis. More than 4000 proteins were quantified, of which 138 were identified as novel osteoclast-related proteins. We selected 5 proteins for subsequent analysis (cystathionine γ-lyase [Cth/CSE], EGF-like repeat and discoidin I-like domain-containing protein 3, integrin α FG-GAP repeat containing 3, adseverin, and serpinb6b) and show that gene expression levels are also increased. Further analysis of the CSE transcript profile reveals an early onset of an mRNA increase. Silencing of CSE by siRNA and dl-propargylglycine, a CSE inhibitor, attenuated receptor activator of nuclear factor κ-B ligand-induced tartrate-resistant acid phosphatase type 5 activity and pit formation, suggesting that CSE is a potent inducer of calcium resorption. Moreover, knockdown of CSE suppressed expression of osteoclast differentiation markers. CONCLUSIONS: Our large-scale proteomics study identified novel candidate regulators or markers for osteoclastogenesis and demonstrated that CSE may act in early stages of osteoclastogenesis.
Authors: Elena Aikawa; Matthias Nahrendorf; Jose-Luiz Figueiredo; Filip K Swirski; Timur Shtatland; Rainer H Kohler; Farouc A Jaffer; Masanori Aikawa; Ralph Weissleder Journal: Circulation Date: 2007-11-26 Impact factor: 29.690
Authors: Eun Young Choi; Emmanouil Chavakis; Marcus A Czabanka; Harald F Langer; Line Fraemohs; Matina Economopoulou; Ramendra K Kundu; Alessia Orlandi; Ying Yi Zheng; Darue A Prieto; Christie M Ballantyne; Stephanie L Constant; William C Aird; Thalia Papayannopoulou; Carl G Gahmberg; Mark C Udey; Peter Vajkoczy; Thomas Quertermous; Stefanie Dimmeler; Christian Weber; Triantafyllos Chavakis Journal: Science Date: 2008-11-14 Impact factor: 47.728
Authors: Rebekah L Gundry; Kimberly Raginski; Yelena Tarasova; Irina Tchernyshyov; Damaris Bausch-Fluck; Steven T Elliott; Kenneth R Boheler; Jennifer E Van Eyk; Bernd Wollscheid Journal: Mol Cell Proteomics Date: 2009-08-04 Impact factor: 5.911
Authors: Susan Dina Ghiassian; Jörg Menche; Daniel I Chasman; Franco Giulianini; Ruisheng Wang; Piero Ricchiuto; Masanori Aikawa; Hiroshi Iwata; Christian Müller; Tania Zeller; Amitabh Sharma; Philipp Wild; Karl Lackner; Sasha Singh; Paul M Ridker; Stefan Blankenberg; Albert-László Barabási; Joseph Loscalzo Journal: Sci Rep Date: 2016-06-09 Impact factor: 4.379